Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Transplant and MSCs for Severe EB
NCT01033552Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Jan 2010
- Primary completion
- Aug 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in epidermolysis bullosa (EB), sponsored by Masonic Cancer Center. Started Jan 2010; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
epidermolysis bullosa (EB)
Beyond the preview
Go deeper on NCT01033552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01033552.